Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05999149 |
|---|---|
| Brief Title: | A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) (BCTOP-T-N01) |
| First Submitted : | August 13, 2023 |
| First Submitted that Met QC Criteria : | August 17, 2023 |
| First Posted : | August 21, 2023 |
| Last Update Submitted that Met QC Criteria : | February 19, 2024 |
| Last Update Posted : | February 21, 2024 |